Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis | Synapse
April 17, 2026
Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis
Key Points
This research aims to explore how the management of proliferative diabetic retinopathy (PDR) has evolved in recent years.
Examined treatment approaches over the past two decades
Compared monotherapy with anti-VEGF to PRP monotherapy
Analyzed trends in clinical practice for PDR management
Shift from PRP monotherapy to anti-VEGF therapy observed
Combination therapy is increasingly used alongside monotherapy
New management strategies are being adopted widely in clinical settings
Abstract
Management of PDR has shifted over the past two decades from PRP monotherapy toward anti-VEGF therapy, including both combination therapy and monotherapy.